SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-09-054129
Filing Date
2009-10-22
Accepted
2009-10-22 15:28:26
Documents
4
Period of Report
2009-10-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 v163487_8k.htm 8-K 23211
2 v163487_ex99-1.htm EX-99.1 1158
3 GRAPHIC v163487_ex99-1x1x1.jpg GRAPHIC 44718
4 v163487_ex99-2.htm EX-99.2 11661
  Complete submission text file 0001144204-09-054129.txt   99908
Mailing Address MIDDLE SECTION, LONGMAO STREET, AREA A LAIYANG WAIXIANGXING INDUSTRIAL PARK LAIYANG CITY, YANTAI, SHANDONG F4 710075
Business Address MIDDLE SECTION, LONGMAO STREET, AREA A LAIYANG WAIXIANGXING INDUSTRIAL PARK LAIYANG CITY, YANTAI, SHANDONG F4 710075 5619889880
Jiangbo Pharmaceuticals, Inc. (Filer) CIK: 0001091164 (see all company filings)

IRS No.: 651130026 | State of Incorp.: FL | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-53037 | Film No.: 091132449
SIC: 2834 Pharmaceutical Preparations